These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1066520)
21. Maintenance therapy of adult acute nonlymphoblastic leukemia: an argument against the need for central nervous system prophlyaxis. Armitage JO; Burns CP Cancer; 1978 Feb; 41(2):697-700. PubMed ID: 272947 [TBL] [Abstract][Full Text] [Related]
22. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study. Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749 [TBL] [Abstract][Full Text] [Related]
23. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685 [TBL] [Abstract][Full Text] [Related]
25. Cell kinetics in leukemia. Correlation with clinical features and response to chemotherapy. Vogler WR; Groth D; Garwood FA Arch Intern Med; 1975 Jul; 135(7):950-4. PubMed ID: 1080405 [No Abstract] [Full Text] [Related]
26. [Treatment of acute leukemia in adults with cytosine arabinoside and thioguanine]. Kotlarek-Haus S; Lawińska B; Kuliszkiewicz-Janus M Acta Haematol Pol; 1978; 9(4):237-42. PubMed ID: 735711 [TBL] [Abstract][Full Text] [Related]
27. Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine. Evans DI; Jones PH; Morley CJ Cancer; 1975 Nov; 36(5):1547-51. PubMed ID: 1059498 [TBL] [Abstract][Full Text] [Related]
28. Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combination. Amadori S; Petti MC; Mastrovincenzo C; Testa MG Acta Haematol; 1979; 61(5):237-42. PubMed ID: 111451 [TBL] [Abstract][Full Text] [Related]
29. [Induction and maintenance treatment of acute myelogenous leukemia in adults by sequential use of combination chemotherapy (author's transl)]. Fülle HH Med Klin; 1977 Apr; 72(15):642-9. PubMed ID: 266111 [TBL] [Abstract][Full Text] [Related]
30. Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): a pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults. Sartiano GP; Pfrimmer WJ; Turner AR Med Pediatr Oncol; 1978; 4(3):205-12. PubMed ID: 277748 [TBL] [Abstract][Full Text] [Related]
31. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria. Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807 [TBL] [Abstract][Full Text] [Related]
32. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia. Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790 [No Abstract] [Full Text] [Related]
33. A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia. Wiernik PH; Glidewell OJ; Hoagland HC; Brunner KW; Spurr CL; Cuttner J; Silver RT; Carey RW; DelDuca V; Kung FH; Holland JF Med Pediatr Oncol; 1979; 6(3):261-77. PubMed ID: 381887 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia. Rühl H; Fülle HH; Koeppen KM; Schwerdtfeger R Klin Wochenschr; 1981 Nov; 59(21):1189-93. PubMed ID: 6947118 [TBL] [Abstract][Full Text] [Related]
35. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response. Kremer WB; Vogler WR; Chan YK Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365 [TBL] [Abstract][Full Text] [Related]
36. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia. Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961 [No Abstract] [Full Text] [Related]
37. Cytosine arabinoside as a single agent in the therapy of adult acute leukemia. Armentrout SA; Burns CP Am J Med Sci; 1974 Sep; 268(3):163-8. PubMed ID: 4531223 [No Abstract] [Full Text] [Related]
38. Cytosine arabinoside and 6-thioguanine in the treatment of childhood acute myeloblastic leukemia. Moreno H; Castleberry RP; McCann WP Cancer; 1977 Sep; 40(3):998-1004. PubMed ID: 269001 [TBL] [Abstract][Full Text] [Related]
39. [Results of cytarabine and 6-thioguanine combination chemotherapy in acute leukemia]. Drings P; Fritsch H; von Kaick G; Moskwa G; Sefrin R Verh Dtsch Ges Inn Med; 1973; 79():353-5. PubMed ID: 4524456 [No Abstract] [Full Text] [Related]
40. [Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)]. Büchner Th; Kamanabroo D; Urbanitz D; Hiddemann W; van de Loo J Blut; 1978 Jun; 36(6):372-6. PubMed ID: 274968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]